ClinicalTrials.gg
CompletedNCT06691711ASPIREUpdated Nov 15, 2024

Adult-caregiver Supported Positive Psychology Intervention to Increase Resilience: Work Package 2

An interventional study of ASPIRE support package in Mental Health, sponsored by Norfolk and Suffolk NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2024-11-15.

Sponsored by Norfolk and Suffolk NHS Foundation Trust · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2022, registered Oct 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
8 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 105 studies in Psychological Well-Being with a site in United Kingdom — 34 open to participants now, 39 under way, none of them phase 3. Psychological Well-Being · United Kingdom.

Enrollment
62nd of 78
24 · median 82
Started
2022
with 9 others
No phase
75 of 105
22 open now
Registered
62nd of 105
by date

Among the 105 studies in Psychological Well-Being with a site in United Kingdom, this one is the 62nd largest by enrollment of the 78 interventional ones that give a count, is one of 10 that started in 2022, is one of 75 with no phase, and was the 62nd registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

34 of the 105 studies in Psychological Well-Being with a site in United Kingdom are open now. Recruiting first, the newest first:

29 more — sign in →

All 34 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 8 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Psychological Well-Being with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this feasibility study was to investigate a new intervention designed to help parents/carers of children aged 8-12 who have experienced adversities to build their child's resilience to mental health difficulties using a 'positive psychology' approach. The research questions concerned the acceptability, feasibility and safety of the intervention.

Read the detailed description

Background: Adverse Childhood Experiences (ACEs) are traumatic or stressful events before age 18 that have been linked to poor mental health across the life course. Resilience is the ability of an individual to maintain or return to a thriving state following adversity. As resilience is not a static trait, intervening to increase the resilience of children exposed to ACEs has the potential to decrease the risk of later mental health difficulties. Positive psychology interventions (i.e. interventions that aim to increase factors that have been identified as important to individual and community flourishing) have been shown to be effective in increasing resilience. However, there was not yet a positive psychology intervention designed to meet the needs of young people exposed to ACEs and their caregivers (parents/carers).

Objectives: To investigate the acceptability, feasibility and safety of a co-produced caregiver-delivered positive psychology intervention to enhance the resilience to mental health difficulties of children who have experienced ACEs.

Methods: The project was guided by a Stakeholder Research Team (SRT) comprising both adults and young people with relevant expertise-by-experience. The study was divided into two work packages. In work package 1, the researchers completed a component analysis of existing positive psychology interventions, and a qualitative study to understand the needs and preferences of young people, parents/carers and professionals. They then conducted a series of intervention development workshops to co-produce the intervention with the SRT, informed by the findings of the component analysis and qualitative study. In work package 2, the researchers carried out a waitlist-controlled feasibility study involving 12 families with a child aged 8-12 years who had experienced ACEs. Families were randomised to receive the intervention either immediately or after a 10-week waiting period and mixed methods data collected to enable us to assess the acceptability, feasibility and safety of the intervention.

03

Conditions studied

  • Mental Health
04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The child's parent or carer identifies that their child has been significantly impacted by one or more Adverse Childhood Experience (ACE).
  • Child is aged 8 to 12 years.
  • Child is willing and able to provide informed assent to participate.
  • The child's parent or carer is willing and able provide parental consent for their child's participation.
  • At least one adult caregiver (aged 18+) is willing and able to provide to participate themselves.

Exclusion criteria

Exclusion criteria:

  • Child is currently under the care of specialist child and adolescent mental health services (CAMHS).
  • There are ongoing safeguarding concerns that might have an impact on the family's ability to participate safely (e.g. ongoing abuse or neglect).
  • The child or their caregiver has a learning disability that would prevent them from accessing the intervention or completing outcome measures (reasonable adjustments will be made to allow families to participate wherever possible).

In addition, professionals involved in supporting caregivers to deliver the intervention (ASPIRE facilitators) will be invited to participate as staff participants.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Immediate intervention

    Those allocated to the immediate arm will be offered the ASIRE support package over a 10 week period immediately post randomisation. The caregiver will be provided with access to all module resources and supported through the programme by a trained practitioner (their ASPIRE facilitator) who offers information, advice and encouragement during the intervention period (providing up to 8 support sessions in total).

    Behavioral: ASPIRE support package

  • No intervention
    Waitlist

    Participants randomised to the waitlist arm will not be denied access to any support or treatment available as part of current service provision during the waiting period. Both young people and parents/carers will be encouraged to continue engaging with any support they already receive and can be referred/self-refer to additional services as required. After the 10-week waiting period is complete, participants randomised to this arm will be offered the ASPIRE intervention as described above.

Interventions

  • BehavioralASPIRE support package

    The ASPIRE support package has a modular structure with core modules that all participating families are encouraged to complete initially, followed by optional modules which the family is supported to select from according to their strengths and needs. Core modules provide psychoeducation for the caregiver and optional modules contain information on the selected positive psychology topic together with instructions for suggested activities to be completed by the caregiver with their child to implement evidence-based positive psychology strategies. All resources can be accessed both electronically via an online portal or via the printed resource pack. Each caregiver is supported through the programme by a trained practitioner who offers regular support sessions (up to 8 in total) to provide information, advice and encouragement. Support sessions can take place face-to-face, by video call or over the phone according to participant preference.

06

What researchers measure

Primary outcomes

  1. Intervention feasibility / fidelity of delivery

    ASPIRE intervention adherence checklist

    Time frame: 10 weeks

  2. Potential risks of the intervention

    Modified Edinburgh Adverse Effects of Psychological Therapy Scale

    Time frame: 10 weeks

  3. Intervention acceptability

    Qualitative acceptability of the intervention from the perspective of children, caregivers and professionals, assessed via interviews and focus groups

    Time frame: 10 weeks

  4. Intervention feasibility / fidelity of delivery

    ASPIRE intervention adherence checklist

    Time frame: 20 weeks

  5. Potential risks of the intervention

    Modified Edinburgh Adverse Effects of Psychological Therapy Scale

    Time frame: 20 weeks

  6. Intervention acceptability

    Qualitative acceptability of the intervention from the perspective of children, caregivers and professionals, assessed via interviews and focus groups

    Time frame: 20 weeks

Secondary outcomes

  1. Me and My Feeling Questionnaire

    16-item measure of mental health difficulties with emotional and behavioural difficulties subscale (child completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

  2. The Student Resilience Survey

    47-item measure measuring children's perceptions of their internal and external resilience (child completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

  3. Students' Life Satisfaction Scale

    7-item measure of global life satisfaction (child completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

  4. Strengths and Difficulties Questionnaire (parent-report version)

    25-item measure of caregiver perception of their child's emotional and behavioural difficulties (parent/carer completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

  5. Me as a Parent

    16-item measure of parental self-regulation, including their self-efficacy, personal agency, self-management and self-sufficiency as a parent (parent/carer completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

  6. Short Warwick Edinburgh Mental Wellbeing Scale

    7-item measure of the parent or carer's mental wellbeing (parent/carer completed)

    Time frame: Post intervention (10 weeks) & 20 week follow-up for immediate arm only

07

Study locations

1 site
  • Norfolk and Suffolk NHS Foundation Trust
    Norwich, Norfolk NR6 5BE, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2022 to primary completion in Sep 2022, 7 months.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's 7 months is below that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 11, 2023
First posted
Nov 15, 2024
StartActual
Jan 31, 2022
Primary completionActual
Sep 27, 2022
CompletionActual
Sep 30, 2022
Last update
Nov 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06691711
Lead sponsor
Norfolk and Suffolk NHS Foundation Trust
Collaborators
University of Oxford, University of Sussex
Responsible party
Sponsor
First posted
Nov 15, 2024
Start date
Jan 31, 2022
Primary completion
Sep 27, 2022
Completion
Sep 30, 2022
Last update
Nov 15, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion